StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CARE.ST$25.30-0.39%
Fair $25.30+0.0%

CARE.ST

Careium AB (Publ)

Industrials / Security & Protection ServicesStockholm

$25.30

-0.10 (-0.39%)

Fairly Valued+0.0%Fair Value $25.30Fund rank 30/100 · Data gapFallback financials|
SA 56/C
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $51.3M · quality 51.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

56/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.8%, below the 5% threshold
Thesis & Journal · CARE.STLocal privado en este navegador · Careium AB (Publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$615M

P/E

18.7x

↑

EV/EBITDA

6.7x

↓

ROE

4.8%

↓

Gross Margin

43.9%

↑

Debt/Equity

0.31

↓
52-Week Range$25
$19$33

TradingView lightweight chart

CARE.ST price, volumen y niveles de valoración

Último $25.30Periodo -21.2%
Fair value: $25.30

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.6%

FCF CAGR

—

FCF margin

6.0%

FCF / Net income

1.58x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $854.1M · net income $32.5M · FCF $51.3M

2022-FY → 2025-FY

Gross margin

43.9%+6.2% pts

Operating margin

5.8%+8.0% pts

Net margin

3.8%+5.4% pts

FCF margin

6.0%+18.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$854.1M$854.1M$870.7M$824.6M$725.1M
Net Income$32.5M$32.5M$58.4M$37.9M$-11.3M
EBITDA$114.6M$114.6M$157.4M$147.5M$67.8M
EPS1.331.332.401.56-0.47
Gross Margin43.9%43.9%42.9%41.3%37.7%
Operating Margin5.8%5.8%9.7%7.2%-2.2%
Net Margin3.8%3.8%6.7%4.6%-1.6%
Balance Sheet
Debt/Equity0.310.310.290.380.52
Current Ratio1.801.80———
Cash Flow
Free Cash Flow$51.3M$51.3M$36.9M$61.9M$-87.1M
Returns
ROE4.8%4.8%8.6%6.3%-2.0%
Valuation
P/E18.7418.7412.4616.28—
EV/EBITDA6.726.725.675.507.33
P/B0.900.901.071.030.43
Growth & Yield
Revenue Growth-1.9%-1.9%5.6%13.7%—
EPS Growth-44.6%-44.6%53.8%431.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

19.1%

exigente

EPS terminal req.

$2.24

Spread vs growth

-63.6%

5Y implied EPS CAGR

15.4%

exigente

EPS terminal req.

$2.72

Spread vs growth

-59.9%

10Y implied EPS CAGR

12.6%

razonable

EPS terminal req.

$4.37

Spread vs growth

-57.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -10.6%

Total return

-10.6%

Start / end P/E

11.8x → 19.0x

EPS bridge

2.40 → 1.33

Residual

-27.3%

EPS growth-44.6%
Multiple rerating+61.3%
Dividend+0.0%
Residual / FX / buybacks / cross-term-27.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.